以岭药业9月9日获融资买入9149.68万元，融资余额7.13亿元

Core Viewpoint - Yiling Pharmaceutical experienced a 2.58% increase in stock price on September 9, with a trading volume of 941 million yuan, indicating positive market sentiment towards the company [1] Financing Summary - On September 9, Yiling Pharmaceutical had a financing buy-in amount of 91.5 million yuan, with a net financing buy of 8.94 million yuan after repayments [1] - The total financing and securities lending balance reached 720 million yuan, with the financing balance at 713 million yuan, accounting for 2.44% of the circulating market value, which is below the 50th percentile of the past year, indicating a low level of financing [1] - In terms of securities lending, 200 shares were repaid, and 13,800 shares were sold short, with a total selling amount of 241,100 yuan, while the securities lending balance stood at 6.8 million yuan, exceeding the 80th percentile of the past year, indicating a high level of short selling [1] Company Performance - As of June 30, Yiling Pharmaceutical had 170,100 shareholders, a decrease of 8.18% from the previous period, while the average circulating shares per person increased by 8.91% to 8,093 shares [2] - For the first half of 2025, Yiling Pharmaceutical reported a revenue of 4.04 billion yuan, a year-on-year decrease of 12.26%, while the net profit attributable to shareholders increased by 26.03% to 669 million yuan [2] - Since its A-share listing, Yiling Pharmaceutical has distributed a total of 3.954 billion yuan in dividends, with 1.337 billion yuan distributed over the past three years [2] Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder with 17.5921 million shares, a decrease of 5.6782 million shares from the previous period [2] - The Southern CSI 500 ETF ranked fifth among circulating shareholders with 12.3965 million shares, an increase of 1.765 million shares [2] - The Huatai-PineBridge CSI Traditional Chinese Medicine ETF was the tenth largest circulating shareholder with 3.8498 million shares, a decrease of 432,500 shares [2]